NCT07930169
Observational Study to Evaluate the Safety and Efficacy of Kremezin IDT/Fine Gran in Progressive Chronic Kidney Disease Patients.
Track this trial
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 1 version: 1 with changes below.
- Study First Submitted
Endpoints
Primary
Proportion of participants with an effective overall assessment at Week 24
Timeframe: Baseline to Week 24 (Week 24 ±3 weeks)
Secondary (4)
Proportion of participants with an effective overall assessment at Week 48
Change from baseline in serum creatinine (Scr) at Weeks 24 and 48
Change from baseline in estimated glomerular filtration rate (eGFR) at Weeks 24 and 48
Mean treatment satisfaction score at Weeks 24 and 48
Sites
1 site in 1 country
- HK inno.NSeoul, South Korea